FR2270892B1 - - Google Patents

Info

Publication number
FR2270892B1
FR2270892B1 FR7416598A FR7416598A FR2270892B1 FR 2270892 B1 FR2270892 B1 FR 2270892B1 FR 7416598 A FR7416598 A FR 7416598A FR 7416598 A FR7416598 A FR 7416598A FR 2270892 B1 FR2270892 B1 FR 2270892B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7416598A
Other languages
French (fr)
Other versions
FR2270892A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST FRANCAIS D IMMUNOLOGIE
Original Assignee
INST FRANCAIS D IMMUNOLOGIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST FRANCAIS D IMMUNOLOGIE filed Critical INST FRANCAIS D IMMUNOLOGIE
Priority to FR7416598A priority Critical patent/FR2270892A1/fr
Publication of FR2270892A1 publication Critical patent/FR2270892A1/fr
Application granted granted Critical
Publication of FR2270892B1 publication Critical patent/FR2270892B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/11011Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7416598A 1974-05-14 1974-05-14 Vaccines from attenuated viruses - which have been serially incubated with yeast cells, especially Saccharomyces cerevisiae Granted FR2270892A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7416598A FR2270892A1 (en) 1974-05-14 1974-05-14 Vaccines from attenuated viruses - which have been serially incubated with yeast cells, especially Saccharomyces cerevisiae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7416598A FR2270892A1 (en) 1974-05-14 1974-05-14 Vaccines from attenuated viruses - which have been serially incubated with yeast cells, especially Saccharomyces cerevisiae

Publications (2)

Publication Number Publication Date
FR2270892A1 FR2270892A1 (en) 1975-12-12
FR2270892B1 true FR2270892B1 (ja) 1978-02-03

Family

ID=9138792

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7416598A Granted FR2270892A1 (en) 1974-05-14 1974-05-14 Vaccines from attenuated viruses - which have been serially incubated with yeast cells, especially Saccharomyces cerevisiae

Country Status (1)

Country Link
FR (1) FR2270892A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (ja) * 1981-08-04 1984-08-04 Univ California
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector

Also Published As

Publication number Publication date
FR2270892A1 (en) 1975-12-12

Similar Documents

Publication Publication Date Title
FR2296334B1 (ja)
AU480152B2 (ja)
AU495841B2 (ja)
AU8191875A (ja)
JPS49149260U (ja)
BG20237A1 (ja)
AU480069A (ja)
AU480469A (ja)
AU481544A (ja)
AU481898A (ja)
AU482332A (ja)
AU482369A (ja)
BE827113A (ja)
BE829575A (ja)
BE830029A (ja)
BG19710A1 (ja)
BG19722A1 (ja)
BG19729A1 (ja)
BG19867A1 (ja)
BG20001A1 (ja)
BG20146A1 (ja)
BG20212A1 (ja)
BG20430A1 (ja)
BG20475A1 (ja)
BG20501A1 (ja)

Legal Events

Date Code Title Description
ST Notification of lapse